Largest pharmaceutical companies in the United States by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by cash on hand, at $19.7B, ahead of Merck & Co ($14.6B) and Bristol-Myers Squibb ($10.2B). Figures as of 20 Nov 2026, 02:03 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
Johnson & Johnson$19.7B
Median
$355.1M
Combined market value
$3.74T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Largest pharmaceutical companies in the United States by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Johnson & JohnsonJNJ · Health Care$19.7B$643.1B$267.14 2.04% down 34% up United States
2Merck & CoMRK · Health Care$14.6B$327.4B$132.81 3.61% down 45% up United States
3Bristol-Myers SquibbBMY · Health Care$10.2B$119.3B$58.34 2.05% down 30% up United States
4Abbott LaboratoriesABT · Health Care$8.5B$179.9B$103.87 0.58% down 16% down United States
5Eli LillyLLY · Health Care$7.3B$1.20T$1,351.12 2.29% down 33% up United States
6AbbVieABBV · Health Care$5.2B$501.2B$283.54 0.86% down 25% up United States
7Vertex PharmaceuticalsVRTX · Health Care$5.1B$132B$520.66 2.94% down 27% up United States
8Regeneron PharmaceuticalsREGN · Health Care$3.1B$95.5B$923.34 2.35% down 28% up United States
9ZoetisZTS · Health Care$2.3B$32.8B$80.79 5.59% down 26% down United States
10Alnylam PharmaceuticalsALNY · Health Care$1.7B$19.8B$147.82 1.06% down 66% down United States
11United TherapeuticsUTHR · Health Care$1.6B$23.8B$559.10 3.16% down 22% up United States
12ViatrisVTRS · Health Care$1.3B$22.8B$19.88 1.97% down 99% up United States
13BioMarin PharmaceuticalBMRN · Health Care$1.3B$11.9B$61.42 0.02% down 17% up United States
14PfizerPFE · Health Care$1.1B$157B$27.54 1.85% down 15% up United States
15PTC TherapeuticsPTCT · Health Care$984.6M$4.9B$58.33 3.16% down 21% down United States
16Legend BiotechLEGN · Health Care$901.9M$3.1B$16.10 0.92% down 41% down United States
17Royalty PharmaRPRX · Health Care$618.7M$38.9B$67.72 1.38% down 79% up United States
18BridgeBio PharmaBBIO · Health Care$570.1M$15.2B$78.18 0.22% up 21% up United States
19Elanco Animal HealthELAN · Health Care$545M$13.1B$26.29 1.54% down 26% up United States
20InsmedINSM · Health Care$510.4M$31.7B$144.46 20.58% up 40% down United States
21Ionis PharmaceuticalsIONS · Health Care$372.3M$4.5B$27.22 0.62% down 63% down United States
22Praxis Precision MedicinesPRAX · Health Care$357.3M$8.7B$310.90 1.87% up 86% up United States
23Belite BioBLTE · Health Care$352.9M$6.1B$151.02 3.33% down 43% up United States
24Axsome TherapeuticsAXSM · Health Care$322.9M$7.1B$135.68 1.25% up 6% down United States
25Cogent BiosciencesCOGT · Health Care$312M$4.8B$27.74 0.25% down 20% down United States
26Mirum PharmaceuticalsMIRM · Health Care$296.7M$6.2B$95.51 3.27% up 34% up United States
27Amneal PharmaceuticalsAMRX · Health Care$282M$7.5B$21.39 2.24% down 90% up United States
28Definium TherapeuticsDFTX · Health Care$257.8M$4B$29.48 1.24% up 168% up United States
29Arrowhead PharmaceuticalsARWR · Health Care$226.5M$6.2B$43.65 1.25% up 13% up United States
30Summit TherapeuticsSMMT · Health Care$225.3M$8.5B$10.57 0.67% up 36% down United States
31Madrigal PharmaceuticalsMDGL · Health Care$198.7M$9.2B$396.74 0.34% down 27% down United States
32Ligand PharmaceuticalsLGND · Health Care$174.9M$5.7B$286.94 3.94% down 50% up United States
33Protagonist TherapeuticsPTGX · Health Care$128.4M$8.1B$124.02 2.47% down 51% up United States
34CytokineticsCYTK · Health Care$122.5M$7.2B$51.46 0.27% up 19% down United States
35Corcept TherapeuticsCORT · Health Care$120.5M$7.1B$64.98 4.15% down 10% down United States
36Travere TherapeuticsTVTX · Health Care$93M$4.6B$48.30 3.86% down 45% up United States
37Spyre TherapeuticsSYRE · Health Care$85.7M$9.3B$97.63 3.77% down 332% up United States
38TG TherapeuticsTGTX · Health Care$79.1M$9.8B$64.88 1.88% down 117% up United States
39ErascaERAS · Health Care$73.8M$5B$14.22 3.34% up 395% up United States
40Edgewise TherapeuticsEWTX · Health Care$61.1M$4.5B$41.17 0.48% down 86% up United States
41Rhythm PharmaceuticalsRYTM · Health Care$54.3M$8.1B$116.80 1.88% down 18% up United States
42Dianthus TherapeuticsDNTH · Health Care$51.1M$4.8B$84.83 1.01% up 108% up United States
43Oruka TherapeuticsORKA · Health Care$46.9M$6.6B$97.57 1.91% up 255% up United States
44VeradermicsMANE · Health Care$21.8M$5.2B$124.39 0.38% down 231% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceutical companies in the United States rank first by cash on hand?

Johnson & Johnson ($19.7B), Merck & Co ($14.6B) and Bristol-Myers Squibb ($10.2B) are the top three of the 44 pharmaceutical companies in the United States ranked by cash on hand as of 20 Nov 2026, 02:03 UTC.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by cash on hand.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by cash on hand have a combined market value of $3.74T as of 20 Nov 2026, 02:03 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.